Kava May Help Alleviate Anxiety

August 16, 2006

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

EXETER, England--Kava (Piper methysticum) may help treat anxiety, though the effect appears to be small, according to the new update of the Cochrane review of the herb (3:CD003383, 2006). Researchers from the University of Exeter identified 22 potentially relevant double blind, placebo controlled, randomized clinical trials for their review; 12 met the inclusion criteria, and included 700 patients. Seven of these trials were included in a meta-analysis that found a significant treatment effect for total score on the Hamilton Anxiety Scale (HAM-A) in favor of kava extract; the five studies that did not use the HAM-A scoring did also have outcomes that supported kava's efficacy. Few adverse events were reported in the trials, and the treatment appears to be relatively safe for short-term (one to 24 weeks) treatment. The researchers concluded further rigorous, long-term trials with larger sample sizes are needed to clarify kava's efficacy and safety.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like